Clinical heterogeneity of Alzheimer's disease. Different clinical profiles can predict the progression rate;Heterogeneidad clínica de la enfermedad de Alzheimer. Diferentes perfiles clínicos pueden predecir el intervalo de progresión

Revista de Neurologia

Volumn 38, Issue 7, 2004, Pages 675-681

  Mangone, Carlos A ^a  

^a Hospital Santojanni Buenos Aires   (Argentina)

Author keywords

Alzheimer's disease; Functional dependency; Heterogeneity; Prognostic rate of progression; Subgroup harmonization

Indexed keywords

AGED; AKINESIA; ALZHEIMER DISEASE; ANOSOGNOSIA; BEHAVIOR DISORDER; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE CLASSIFICATION; DISEASE COURSE; EDUCATION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FUNCTIONAL DISEASE; HALLUCINATION; HUMAN; HYPERACTIVITY; MALE; MENTAL DISEASE; MYOCLONUS; RIGIDITY; CEREBELLUM; CLASSIFICATION; COMPARATIVE STUDY; EDUCATIONAL STATUS; EXTRAPYRAMIDAL SYNDROME; FRONTAL LOBE; HOSPITALIZATION; HYPERKINESIA; NEUROLOGIC EXAMINATION; ONSET AGE; PATHOPHYSIOLOGY; PERCEPTION DISORDER; REVIEW; SMELLING DISORDER; TIME;

ACTIVITIES OF DAILY LIVING; AGE OF ONSET; ALZHEIMER DISEASE; BASAL GANGLIA DISEASES; CEREBELLUM; DISEASE PROGRESSION; EDUCATIONAL STATUS; FRONTAL LOBE; HALLUCINATIONS; HUMANS; HYPERKINESIS; MENTAL DISORDERS; MYOCLONUS; NEUROLOGIC EXAMINATION; OLFACTION DISORDERS; PERCEPTUAL DISORDERS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 2942722489     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3807.2003542     Document Type: Conference Paper

References (47)

1. Mc Khann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
2. American Psychiatric Association. Diagnostic criteria from DSM-IV. Washington DC: APA; 1994.
3. Liston EH. The clinical phenomenology of preseniles dementia: a critical review of the literature. J Nerv Ment Dis 1979; 2: 329-36.
4. Ritchie K, Touchon J. Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical subtypes? J Clin Epidemiol 1992; 45: 1391-8.
5. Reisberg B, Ferris SH, DeLeon MJ, Crook T. The global deterioration scale of assessment of primary degenerative dementia. Br J Psychiatry 1982; 139: 1136-9.
6. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for staging of dementia. Br J Psychiatry 1982; 140: 566-72.
7. Katzman R, Terry R, De Teresa R, Brown T, Davies P, Fuld P, et al. Clinical, pathological and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988; 23: 138-44.
8. Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol 1988; 45: 789-93.
9. Jorn AF. Subtypes of Alzheimer's dementia: a conceptual analysis and critical review. Psychol Med 1985; 15: 543-53.
10. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985; 35: 453-61.
11. Huff JF, Boller F, Lucchelli F, Querriera R, Beyer J, Belle S. The neurologic examination in patient with probable Alzheimer's disease. Arch Neurol 1987; 44: 929-32.
12. Mangone CA, Allegri RF. Heterogeneidad clínica de la enfermedad de Alzheimer. In Mangone CA, Allegri RF, Arizaga RL, Famulari A, Fustinoni O, Ollari JA, et al, eds. Enfermedad de Alzheimer. Enfoque actual. Buenos Aires: Libros de la Cuadriga-Argentum Editora; 1995. p. 203-16.
13. Solomon GS, Petrie WM, Hart JR, Brackin HB Jr. Olfactory dysfunction discriminates Alzheimer's dementia from major depression. J Neuropsychiatry Clin Neurosci 1998; 10: 64-7.
14. Bacon AW, Bondi MW, Salmon DP, Murphy C. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Ann N Y Acad Sci 1998; 855: 723-31.
15. Koss E, Weffenbach J, Haxby JV, Frieland RP. Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology 1988; 38: 1228-32.
16. Visser H. Gait and balance in senile dementia of Alzheimer's type. Age Aging 1983; 12: 296-301.
17. Leverenz J, Sumi SM. Parkinson's disease in patients with Alzheimer's disease. Arch Neurol 1986; 43: 662-4.
18. Hansen LA, Salmon D, Galasko D. The Lewy variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990; 40: 1-8.
19. Hauser WA, Morris ML, Heston LL, Anderson VE. Seizures and myoclonus in patients with Alzheimer's disease. Neurology 1986; 36: 1226-30.
20. Pro JD, Smith CH, Sumi SM. Presenile Alzheimer's disease: amyloid plaques in the cerebellum. Neurology 1980; 30: 820-5.
21. Seltzer B, Sherwin Y. A comparison of clinical features in early and late onset primary degenerative dementia. One entity or two. Arch Neurol 1983; 40: 143-6.
22. Selnes OA, Carson K, Rovner B, Gordon B. Language dysfunction in early-onset and late-onset possible Alzheimer's disease. J Neurol Neurosurg Psychiatry 1984; 47: 1138-40.
23. Folstein MF, Folstein SE, McHugh PR. Mini Mental State. A practical method for grading the cognitive state for the clinician. J Psychiatr Res 1975; 12: 189-98.
24. Weschler D. Tests de inteligencia para adultos (WAIS). Buenos Aires: Paidós; 1988.
25. Kaplan EF, Goodglass H, Weintraub S. The Boston naming test. 2 ed. Philadelphia: Lea & Febiger; 1983.
26. Allegri RF, Mangone CA, Fernández-Villavicencio A, Rymberg S, Taragano FE, Bauman D. Spanish version of the Boston Naming Test. Clin Neuropsychologist 1997; 11: 416-20.
27. Fustinoni O, Mangone CA, Abiusi GP, Caccuri R, Labos E. Primary progressive aphasia. Clinical subtypes with one postmortem study. Neurology 1994; 44 (Suppl 2): S387.
28. Mangone CA, Hier DB, Ganellen R, Gorelick PB. Psychotic and behavioral symptoms in Alzheimer's disease. Neuropsychological correlations. Revista Neurológica Argentina 1991; 16: 166-72.
29. Kumer A, Koss E. Behavioral symptomatology in dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 1988; 2: 363-5.
30. Cummings J. Organic delusions. Br J Psychiatry 1985; 146: 184-97.
31. Cummings J, Victoroff J. Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1990; 3: 140-58.
32. Mangone CA, De Pascale AM, Bauman D, Arizaga RL, Allegri RF, Ollari JA, et al. Síntomas psiquiatricos y conductuales. Predicción según nivel de deterioro. 18th International Conference of Alzheimer's Disease International. Barcelona, Spain, October 26, 2002.
33. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotes A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 48: 9-15.
34. Blessed G, Tomlinson B, Roth M. The association between quantitative measures of dementia and senile changes in cerebral gray matter of elderly subjects. Br J Psychiatry 1986; 114: 797-811.
35. SCAN. Schedule for clinical assessment in neuropsychiatry. Version 2. Geneva: World Health Organization; 1994.
36. Taragano F, Mangone CA. Depression in the old. IPA Bulletin 1995; 12: 28-9.
37. Lazarus L, Newton N, Cohler B, Lesser J, Schweon C. Frequency in presentation of depressive symptoms in patients with primary degenerative dementia. Am J Psychiatry 1987; 144: 41-5.
38. Zubenko GS, Moosy J, Kopp U. Neurochemical correlates of mayor depression in primary dementia. Arch Neurol 1990; 47: 209-14.
39. Cummings JL. Disturbances of mood and affect. In Cummings JL. Clinical neuropsychiatry. Boston: Allyn & Bacon; 1992. p. 183-208.
40. Tassin J, Stinus L, Simon H, Blanc G, Thierry A, LeMoal M, et al. Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the frontocortical dopaminergic innervetion in the rat brain. Brain Res 1978; 141: 2673-81.
41. Deutsch L, Bylsma F, Rounus BW, Steele C, Folstein MF. Psychosis and physical aggression in probable Alzheimer disease. Am J Psychiatry 1991; 148: 1159-63.
42. Mangone CA, Hier DB, Gorelick PB, Ganellen R. Impaired insight in Alzheimer's disease. J Geriatr Psychiatry Neurol 1991; 4: 189-93.
43. Weschler D. Weschler memory scale-revised. N. York: Harcourt; 1987.
44. Mangone CA, Allegri RF, Gabay PD, Bauman D, Litvan I, Sica REP. Predicting dependency in ADL in patients with AD. Neurology 1996; 46: 434.
45. Storandt M, Grant EA, Miller JP, Morris JC. Rate of progression in mild cognitive impairment and early Alzheimer disease. Neurology 2002; 59: 1034-41.
46. Sánchez JL, Rodríguez M, Carro J. Influence of cognitive reserve on neuropsychological functioning in Alzheimer's disease type sporadic in subjects of Spanish nationality. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15: 113-22.
47. Shadler MF, Mc Cormick WC, Larson EB. Research agenda for understanding Alzheimer's disease in diverse populations work group on cultural diversity Alzheimer association. Alzheimer Dis Assoc Disord 2002; 16 (Suppl 2): S96-100.